Makoto Daimon
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Hormonal Regulation and Hypertension 15
- Pituitary Gland Disorders and Treatments 14
- Diabetes Treatment and Management 12
-
- Porphyrin Metabolism and Disorders 19
- Metabolism, Diabetes, and Cancer 11
- Co-authors
- Takeo Kato (94 shared papers)Makoto TOMINAGA (41 shared papers)Toshihide Oizumi (41 shared papers)Wataru Kameda (34 shared papers)Hiroshi Ohnuma (32 shared papers)Toru Kawanami (23 shared papers)Masahiko Igarashi (26 shared papers)Hiroshi Yamaguchi (25 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (13 papers)Diabetes Care (9 papers)Metabolism (8 papers)Diabetes Research and Clinical Practice (7 papers)Peptides (7 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Makoto Daimon
231 papers receiving 6.8k citations
Makoto Daimon's Hit Papers
Peers
Comparison fields: 5 of 153
- Endocrinology, Diabetes and Metabolism 1.4k
- Endocrine and Autonomic Systems 232
- Cardiology and Cardiovascular Medicine 713
- Nephrology 229
- Neurology 238
Countries citing papers authored by Makoto Daimon
This map shows the geographic impact of Makoto Daimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Daimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Daimon more than expected).
Fields of papers citing papers by Makoto Daimon
This network shows the impact of papers produced by Makoto Daimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Daimon. The network helps show where Makoto Daimon may publish in the future.
Co-authors
The 25 scholars most cited alongside Makoto Daimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Hit paper breakdown → | 2019 | 836 |
| 2 | 2003 | 307 | |
| 3 | 2017 | 254 | |
| 4 | 2014 | 191 | |
| 5 | 2011 | 172 | |
| 6 | 2008 | 160 | |
| 7 | 1990 | 147 | |
| 8 | Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation Hit paper breakdown → | 2023 | 142 |
| 9 | 2014 | 141 | |
| 10 | 2018 | 133 | |
| 11 | 2008 | 124 | |
| 12 | 2006 | 117 | |
| 13 | 2004 | 105 | |
| 14 | 2007 | 94 | |
| 15 | 2008 | 88 | |
| 16 | 2006 | 83 | |
| 17 | 2016 | 80 | |
| 18 | 2016 | 80 | |
| 19 | 1988 | 74 | |
| 20 | 2003 | 69 |
About Makoto Daimon
Makoto Daimon is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology, Behavioral Neuroscience and Epidemiology, having authored 237 papers that have together received 7.0k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Hormonal Regulation and Hypertension (15 papers), Pancreatic function and diabetes (14 papers), Pituitary Gland Disorders and Treatments (14 papers), Stress Responses and Cortisol (12 papers), Diabetes Treatment and Management (12 papers) and Metabolism, Diabetes, and Cancer (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Endocrine and Autonomic Systems (232 citations), Cardiology and Cardiovascular Medicine (713 citations), Nephrology (229 citations) and Neurology (238 citations). Makoto Daimon has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takeo Kato, Makoto TOMINAGA, Toshihide Oizumi, Wataru Kameda, Hiroshi Ohnuma, Toru Kawanami, Masahiko Igarashi, Hiroshi Yamaguchi, Takamasa Kayama and Kazunori Kageyama. Their work appears in journals such as Biochemical and Biophysical Research Communications, Diabetes Care, Metabolism, Diabetes Research and Clinical Practice and Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.